Silence Therapeutics (SLN) Cash from Operations (2020 - 2026)
Silence Therapeutics recorded quarterly Cash from Operations of 15600000.0 in Q1 2026, up 9.68% quarter-over-quarter from 17271000.0 in Q4 2025, and down 26.74% year-over-year from 21293013.97 in Q1 2025.
Silence Therapeutics' Cash from Operations history runs 7 years deep, the most recent figure standing at 15600000.0 for Q1 2026.
- In Q1 2026, Cash from Operations fell 26.74% year-over-year to 15600000.0; the TTM figure through Mar 2026 stood at 65562000.0 (up 8.18% YoY), while the FY2025 annual figure was 62271000.0, up 7.94% from the prior year.
- Cash from Operations came in at 15600000.0 for Q1 2026 at Silence Therapeutics, up from 17271000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 6076330.67 in Q2 2024 to a low of 27481000.0 in Q4 2024.
- A 5-year average of 15250072.05 and a median of 15600000.0 in 2026 frame the typical range for Cash from Operations.
- Across the five-year window, Cash from Operations slumped 429.09% in 2022 and jumped 67.53% in 2024, its largest moves.
- Silence Therapeutics' Cash from Operations stood at 15726622.93 in 2022, then slumped by 42.66% to 22436302.63 in 2023, then retreated by 22.48% to 27481000.0 in 2024, then soared by 37.15% to 17271000.0 in 2025, then grew by 9.68% to 15600000.0 in 2026.
- According to Business Quant data, Cash from Operations over the past three periods registered 15600000.0, 17271000.0, and 10907000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.43 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.08 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 70.50 Mn |
| 10 | Silence Therapeutics | 924.61 Mn | 854.53 Mn | 411,000.00 | -15.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.60 Mn |
| Mar 31, 2026 | -15.60 Mn |
| Dec 31, 2025 | -17.27 Mn |
| Dec 31, 2025 | -17.27 Mn |
| Sep 30, 2025 | -10.91 Mn |
| Sep 30, 2025 | -10.91 Mn |
| Jun 30, 2025 | -21.78 Mn |
| Jun 30, 2025 | -21.78 Mn |
| Mar 31, 2025 | -12.31 Mn |
| Mar 31, 2025 | -12.31 Mn |
| Dec 31, 2024 | -27.48 Mn |
| Dec 31, 2024 | -27.48 Mn |
| Sep 30, 2024 | -25.54 Mn |
| Sep 30, 2024 | -25.54 Mn |
| Jun 30, 2024 | -6.08 Mn |
| Jun 30, 2024 | -6.08 Mn |
| Mar 31, 2024 | -9.14 Mn |
| Mar 31, 2024 | -9.14 Mn |
| Dec 31, 2023 | -22.44 Mn |
| Dec 31, 2023 | -22.44 Mn |
| Sep 30, 2023 | -6.17 Mn |
| Sep 30, 2023 | -6.17 Mn |
| Jun 30, 2023 | -18.72 Mn |
| Jun 30, 2023 | -18.72 Mn |
| Mar 31, 2023 | -9.31 Mn |
| Mar 31, 2023 | -9.31 Mn |
| Dec 31, 2022 | -15.73 Mn |
| Dec 31, 2022 | -15.73 Mn |
| Sep 30, 2022 | -11.08 Mn |
| Sep 30, 2022 | -11.08 Mn |
| Jun 30, 2022 | -10.41 Mn |
| Jun 30, 2022 | -10.41 Mn |
| Mar 31, 2022 | -19.29 Mn |
| Mar 31, 2022 | -19.29 Mn |
| Dec 31, 2021 | -2.97 Mn |
| Dec 31, 2021 | -2.97 Mn |
| Sep 30, 2021 | -6.79 Mn |
| Sep 30, 2021 | -6.79 Mn |
| Jun 30, 2021 | 36.38 Mn |
| Jun 30, 2021 | 36.38 Mn |
| Mar 31, 2021 | -16.68 Mn |
| Mar 31, 2021 | -16.68 Mn |
| Dec 31, 2020 | -7.14 Mn |
| Dec 31, 2020 | -7.14 Mn |
| Sep 30, 2020 | -8.01 Mn |
| Sep 30, 2020 | -8.01 Mn |